Takeda Pharmaceutical Co (NYSE:TAK) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Takeda Pharmaceutical Co (TAK) operate in?

Takeda Pharmaceutical Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Takeda Pharmaceutical Co Stock (NYSE: TAK) stock price, news, charts, stock research, profile.

Open	$13.23
Close	$13.27
Volume / Avg.	1.19M / 1.67M
Day Range	$13.21 - $13.32
52 Wk Range	12.58 - 15.08
Market Cap	$42.07B
P/E Ratio	22.71
Dividend Yield	4.96%
Exchange	NYSE
RSI	38
Short Interest	0.14%
Days to Cover	2.72

Recent News

Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency

Takeda's HYQVIA receives approval in Japan for treating immunodeficiencies, offering a more convenient, less frequent subcutaneous infusion option.

Nabaparna Bhattacharya

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

Teva and Sanofi report positive Phase 2b data for duvakitug, showing significant remission in UC and CD patients, boosting analyst confidence and price targets.

Vandana Singh

Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst

Takeda inks a licensing deal with Keros for elritercept, a late-stage anemia drug, and plans a Phase 3 trial in myelodysplastic syndromes.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$13.23
Close	$13.27
Volume / Avg.	1.19M / 1.67M
Day Range	$13.21 - $13.32
52 Wk Range	12.58 - 15.08
Market Cap	$42.07B
P/E Ratio	22.71
Dividend Yield	4.96%
Exchange	NYSE
RSI	38
Short Interest	0.14%
Days to Cover	2.72

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Takeda Pharmaceutical Co (TAK) stock?

You can purchase shares of Takeda Pharmaceutical Co (NYSE:TAK) through any online brokerage.

View our list of the best stock brokerages

Who are Takeda Pharmaceutical Co (TAK) competitors?

Other companies in Takeda Pharmaceutical Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Takeda Pharmaceutical Co (TAK) stock?

Takeda Pharmaceutical Co has a consensus price target of $21.33.

What is the current price for Takeda Pharmaceutical Co (TAK)?

The stock price for Takeda Pharmaceutical Co (NYSE: TAK) is $13.27 last updated December 27, 2024 at 4:00 PM EST.

Does Takeda Pharmaceutical Co (TAK) pay a dividend?

A quarterly cash dividend of 0.33 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2024 to stockholders of record on September 30, 2024.

When is Takeda Pharmaceutical Co (NYSE:TAK) reporting earnings?

Takeda Pharmaceutical Co’s Q3 earnings are confirmed for Thursday, January 30, 2025.

Is Takeda Pharmaceutical Co (TAK) going to split?

There is no upcoming split for Takeda Pharmaceutical Co.

What sector and industry does Takeda Pharmaceutical Co (TAK) operate in?

Takeda Pharmaceutical Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Comments

Takeda Pharmaceutical Co

Takeda Pharmaceutical Co (TAK) Forecast